查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420412

全球夜间隐形眼镜市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按指示、按最终用户、按地区

Night Contact Lens Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 350 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计2024年全球夜间隐形眼镜市场规模将达9亿美元，复合年增长率(CAGR)为10%，呈现强劲成长，预计2031年底将达到17亿美元。近视指示占据市场主导地位，2023 年将占据 53.6% 的重要市场份额。其中，夜间隐形眼镜销售额占同年全球隐形眼镜市场总销售额约5.6%。

角膜塑形术是一种使用特殊隐形眼镜有意修改角膜前表面的方法，为摘除镜片后矫正屈光不正提供暂时且不可逆的解决方案。现代 Ortho-K 使用由硬质高透氧材料製成的反向几何镜片，过夜佩戴可矫正屈光不正并改变前角膜的形状。

随着近视盛行率显着增加，估计影响全球超过10亿人，需要解决和缓解与近视相关的眼科问题。儿童和青少年近视的迅速增加，尤其是在东亚国家，增加了对角膜塑形镜等创新治疗的需求，这种治疗可以治疗所有年龄层的近视、远视和散光。

角膜塑形术被认为是一种安全有效的光学矫正方法，因其减少儿童近视以及改善整体视力和生活品质的其他好处而变得流行。早期开始角膜塑形术可以降低低龄近视儿童高度近视的盛行率。

专为夜间配戴 Ortho-K 设计的透气 (GP) 镜片比轻度视力处方显示出更高的成功率。在FDA进行的角膜屈光治疗（CRT）和视力矫正治疗（VST）镜片的临床试验中，超过65%的ortho-k患者达到了20/20的视力，超过90%的患者达到了20/40或更好. 已经取得了令人印象深刻的视力结果，包括达到 的视力。

该报告研究了全球夜间隐形眼镜市场，并提供了市场概况，包括按适应症、最终用户、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第一章执行摘要

第二章市场概况

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • COVID-19 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE分析

第三章 2018-2031年全球夜间隐形眼镜市场前景

  • 2018-2031 年全球夜间隐形眼镜市场前景（依指标、价值（百万美元））
  • 全球夜间隐形眼镜市场前景，按最终用户划分，价值（百万美元），2018-2031
  • 2018-2031 年全球夜间隐形眼镜市场前景（按地区、价值（百万美元））

第四章 2018-2031年北美夜间隐形眼镜市场前景

第5章 2018-2031年欧洲夜间隐形眼镜市场前景

第六章 2018-2031 年亚太地区夜间隐形眼镜市场展望

第七章 2018-2031 年拉丁美洲夜间隐形眼镜市场展望

第8章 2018-2031年中东和非洲夜间隐形眼镜市场前景

第9章 竞争格局

  • 按产品和最终用户划分的热图
  • 2023 年公司市场份额分析
  • 比赛仪表板
  • 公司简介
    • Cooper Vision
    • Euclid Systems
    • Johnson & Johnson
    • Bausch & Lomb
    • Truform Optics
    • Art Optical Contact Lens, Inc.
    • Menicon Co., Ltd./Alpha
    • Brighten Optix
    • Eyebright Medical Technology Beijing Co Ltd
    • Lucid
    • Optact International Ltd.

第10章附录

简介目录

In the year 2024, the global night contact lens market reached a valuation of US$ 900 million and is projected to witness robust growth with a Compound Annual Growth Rate (CAGR) of 10%, ultimately reaching US$ 1700 million by the conclusion of 2031. According to Fairfield Market Research, myopia indication dominated the market, holding a substantial market value share of 53.6% in 2023. Notably, night contact lens sales contributed to around 5.6% of the total revenue share in the global contact lens market during the same year.

Orthokeratology, a method involving the purposeful modification of the anterior cornea using specialized contact lenses, offers a temporary and irreversible solution to eliminate refractive errors post-lens removal. Modern ortho-k employs reverse geometry lenses constructed with hard, highly oxygen-permeable materials to correct refractive errors and reshape the anterior cornea when worn overnight.

Estimates project a considerable increase in myopia prevalence, affecting over 1 billion people globally, necessitating the addressing and mitigation of myopia-related ophthalmic issues. The surge in myopia, particularly among children and teenagers in East Asian countries, has fueled the demand for innovative treatments like ortho-k lenses, which can treat myopia, hyperopia, and astigmatism across all age groups.

Orthokeratology, recognized as a safe and effective method for optical correction, has gained popularity for its additional benefits of reducing childhood myopia and enhancing overall eyesight and quality of life. Early initiation of ortho-k therapy may potentially reduce the prevalence of high myopia in younger myopic children.

Gas permeable (GP) lenses designed for ortho-k, worn overnight, have demonstrated higher success rates than mild vision prescriptions. Clinical trials conducted by the FDA on corneal refractive therapy (CRT) and vision shaping treatment (VST) lenses revealed impressive visual acuity results, with over 65% of ortho-k patients achieving 20/20 vision and more than 90% achieving 20/40 or greater vision.

Market Expansion Strategies for Night Contact Lens Manufacturers:

Better Alternative than Laser Vision Correction (LASIK)

While laser corrective surgery offers a long-term solution for vision issues, it comes with potential risks such as severe dry eye, impaired vision, and infections. In contrast, ortho-k presents a safer alternative without side effects, approved by the FDA for both children and adults. Recent advancements in ortho-k designs, like MOONLENS and REMlens, have improved myopia control, and ongoing research explores its potential as a permanent myopia treatment.

Ortho-k lenses, being a cost-effective alternative to laser surgery, offer clear vision during the day without compromising corneal integrity. Athletes and sports enthusiasts find them particularly appealing for their all-day clear vision without the need for prescription lenses or glasses, enhancing their overall experience.

Challenges and Considerations in Night Contact Lens Market Expansion:

Lack of Availability of Long-term Data

While ortho-k provides short-term benefits, it is not without risks and adverse effects similar to standard soft contact lenses. Regular follow-ups and aftercare visits are essential, making it a time-consuming process. The small size and transparency of ortho-k lenses pose challenges, especially for children, who may easily lose them. Additionally, wearing night contact lenses every night to maintain corneal shape can be tedious, and success in slowing down myopia progression is not guaranteed.

Country-wise Market Insights:

U.S. Market: Vision-Associated Issues on the Rise

The U.S. remains the dominant player in the North American market. Research indicates a significant prevalence of vision impairments among Americans, with a substantial portion using contact lenses. Prolonged screen time, particularly among individuals aged 16 to 25, is contributing to the growing issue of vision problems, underscoring the demand for effective solutions such as night contact lenses.

Germany Market: Technology Advancements Drive Growth

Germany holds a substantial share of the European market, with a promising outlook driven by advancements in ortho-k technology. Eye care manufacturers based in Germany are expanding their reach globally, introducing innovative products to meet the increasing demand for ortho-k lenses.

China Market: Surge in Clinical Trials and Studies

China maintains its dominant position in the East Asia market. Numerous ortho-K manufacturers, including Paragon, Lucid, Euclid, and ProCornea, operate in China. The presence of well-established lens companies like Bausch+Lomb and Cooper Vision, along with a notable increase in clinical trials, solidifies China's status as a significant player in the global night contact lens market.

Competitive Analysis:

Leading manufacturers are introducing innovative products to expand their global market presence.

Key Companies Profiled:

  • Cooper Vision
  • Euclid Systems
  • Johnson & Johnson
  • Bausch & Lomb
  • Truform Optics
  • Art Optical Contact Lens, Inc.
  • Menicon Co., Ltd. Alpha
  • Brighten Optix
  • Eyebright Medical Technology Beijing Co Ltd
  • Lucid
  • Optact International Ltd.
  • Taiwan Macro Vision Corporation
  • E & E optics
  • GP Specialists
  • MiracLens L.L.C.
  • Laboratoire LCS
  • Multilens AB
  • Falco lenses AG
  • EIKON
  • Biolens Lab

Key Segments of Night Contact Lens Industry Research

By Indication:

  • Myopia
  • Astigmatism
  • Hyperopia
  • Presbyopia

By End User:

  • Hospitals
  • Ophthalmology Clinics
  • Vision Care Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Night Contact Lens Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Night Contact Lens Market Outlook, 2018 - 2031

  • 3.1. Global Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Myopia
      • 3.1.1.2. Astigmatism
      • 3.1.1.3. Hyperopia
      • 3.1.1.4. Presbyopia
  • 3.2. Global Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Ophthalmology Clinics
      • 3.2.1.3. Vision Care Centers
  • 3.3. Global Night Contact Lens Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Night Contact Lens Market Outlook, 2018 - 2031

  • 4.1. North America Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Myopia
      • 4.1.1.2. Astigmatism
      • 4.1.1.3. Hyperopia
      • 4.1.1.4. Presbyopia
  • 4.2. North America Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Ophthalmology Clinics
      • 4.2.1.3. Vision Care Centers
  • 4.3. North America Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 4.3.1.2. U.S. Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.3.1.3. Canada Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 4.3.1.4. Canada Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Night Contact Lens Market Outlook, 2018 - 2031

  • 5.1. Europe Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Myopia
      • 5.1.1.2. Astigmatism
      • 5.1.1.3. Hyperopia
      • 5.1.1.4. Presbyopia
  • 5.2. Europe Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Ophthalmology Clinics
      • 5.2.1.3. Vision Care Centers
  • 5.3. Europe Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.2. Germany Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.3. U.K. Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.4. U.K. Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.5. France Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.6. France Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.7. Italy Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.8. Italy Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.9. Turkey Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.10. Turkey Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.11. Russia Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.12. Russia Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Night Contact Lens Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Myopia
      • 6.1.1.2. Astigmatism
      • 6.1.1.3. Hyperopia
      • 6.1.1.4. Presbyopia
  • 6.2. Asia Pacific Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Ophthalmology Clinics
      • 6.2.1.3. Vision Care Centers
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.2. China Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.3. Japan Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.4. Japan Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.5. South Korea Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.6. South Korea Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.7. India Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.8. India Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Night Contact Lens Market Outlook, 2018 - 2031

  • 7.1. Latin America Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Myopia
      • 7.1.1.2. Astigmatism
      • 7.1.1.3. Hyperopia
      • 7.1.1.4. Presbyopia
  • 7.2. Latin America Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Ophthalmology Clinics
      • 7.2.1.3. Vision Care Centers
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.2. Brazil Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.3. Mexico Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.4. Mexico Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.5. Argentina Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.6. Argentina Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Night Contact Lens Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Night Contact Lens Market Outlook, by Indication, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Myopia
      • 8.1.1.2. Astigmatism
      • 8.1.1.3. Hyperopia
      • 8.1.1.4. Presbyopia
  • 8.2. Middle East & Africa Night Contact Lens Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Ophthalmology Clinics
      • 8.2.1.3. Vision Care Centers
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Night Contact Lens Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.2. GCC Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.3. South Africa Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.4. South Africa Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.5. Egypt Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.6. Egypt Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.7. Nigeria Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.8. Nigeria Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Night Contact Lens Market by Indication, Value (US$ Mn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Night Contact Lens Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Product vs by End User Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Cooper Vision
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Therapy Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Euclid Systems
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Therapy Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Johnson & Johnson
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Therapy Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Bausch & Lomb
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Therapy Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Truform Optics
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Therapy Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Art Optical Contact Lens, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Therapy Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Menicon Co., Ltd./ Alpha
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Therapy Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Brighten Optix
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Therapy Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Eyebright Medical Technology Beijing Co Ltd
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Therapy Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Lucid
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Therapy Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Optact International Ltd.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Therapy Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations